Vaccination Season - Review of the Community Pharmacy Sector - Irish Pharmacy Union
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
IRELAND’S OFFICIAL PHARMACY PUBLICATION
SEPTEMBER 2017
2017/18
ePortfolio
Review
Review
of the
Community
Pharmacy
Sector
Vaccination
Season
MANAGING PAIN IN PHARMACY | ADHERENCE IN ASTHMA | BRANDING
®
Olmesartan Medoxomil
Powerful Blood Pressure Reduction 1,2
Powerful Price Reduction 3,4
Omesar’s proven efficacy is now
more affordable than ever 1-5
Omesar 10, 20, 40 mg film-coated tablets (olmesartan medoxomil). Prescribing information Please consult pregnancy and change to alternative therapy, if appropriate, if pregnancy is planned or occurs during therapy.
the Summary of Product Characteristics (SPC) for full prescribing information. Presentation: Film-coated tablets Excessive blood pressure decrease in patients with ischaemic heart disease or ischaemic cerebrovascular
containing 10 mg, 20 mg, 40 mg olmesartan medoxomil. Contains lactose monohydrate. Uses: Treatment of disease could result in a myocardial infarction or stroke. Contains lactose. Interactions: Not recommended
essential hypertension in adults. Treatment of hypertension in children and adolescents from 6 to less than 18 for concomitant use with ACE-inhibitors, angiotensin II receptor blockers, aliskiren, drugs affecting potassium
years of age. Dosage: Oral administration. Adults (18-65 years): Recommended starting dose 10 mg daily. If levels, lithium. The blood pressure lowering effect of olmesartan medoxomil can be increased by concomitant
required the dose may be increased to 20 mg daily. Maximum daily dose is 40 mg. Elderly (65 years or over): No use with other antihypertensive medications. Risk of acute renal failure with concomitant use of NSAID’s and
dose adjustment generally required. If up-titration to maximum dosage required, monitor blood pressure closely. angiotensin II antagonists. Monitoring of renal function and regular hydration of the patient is recommended. Use
Patients with renal and moderate hepatic impairment: Maximum daily dose is 20 mg. Not recommended in with NSAID’s can reduce the effect of olmesartan medoxomil. Coadministration of warfarin and digoxin had no
patients with severe hepatic impairment. Children and adolescents aged 6 to less than 18 years: As for adults. significant effect on the pharmacokinetics of olmesartan, warfarin or digoxin. No clinically relevant interactions
Daily dose should not exceed 20 mg in children < 35 kg. Safety and efficacy not established in children aged between olmesartan and drugs metabolised by cytochrome P450 enzymes 1A1/2, 2A6, 2C8/9, 2C19, 2D6 and
1 to 5 years. Not recommended for children under 1 year of age. Contra-indications: Hypersensitivity to any 3A4 are expected. Consider administration at least 4 hours before colesevelam dose to decrease interaction
component. Second or third trimesters of pregnancy. Patients with biliary obstruction. Concomitant use with effect. Interaction studies only performed in adults. Not known if interactions in children are similar. Pregnancy
aliskiren-containing products in patients with diabetes mellitus or renal impairment. Warnings and Precautions: and lactation: Do not use in the first trimester and discontinue as soon as possible if pregnancy occurs during
Correct intravascular volume depletion before administering olmesartan medoxomil. In patients with other therapy. Contraindicated in second and third trimester of pregnancy. Not recommended during lactation,
conditions associated with stimulation of renin-angiotensin-aldosterone system, possible side effects include change to alternative therapy, if appropriate. Side Effects: Common (≥1/100 to
SEPTEMBER 2017
07 A Note from the Editor
IPU News
The latest news and events
from Butterfield House
08 Pharmacy in the Media
08 Dates for your Diary
09 IPU Training Programme Autumn 2017
The IPU Review is published
monthly and circulated to Irish 10 IPU Academy Autumn Programme:
pharmacists. The views expressed 18 September 2017
20
by contributors are not those
of the IPU nor is responsibility
accepted for claims in articles
or advertisements.
Subscription:
€95 (Ireland North & South) and
€140 (including postage overseas).
Publisher:
Irish Pharmacy Union
(IPU Services Ltd),
Butterfield House,
Butterfield Avenue,
Rathfarnham, Dublin 14,
D14 E126
Tel: (01) 493 6401
Fax: (01) 493 6626
Features
Email: ipureview@ipu.ie
Website: www.ipu.ie
Editor: Jack Shanahan MPSI
Editorial Associates:
Aoibheann Ní Shúilleabháin, 12 HPV Vaccination Alliance Launched
Jim Curran and Ciara Browne Organisations sign Contract Against Cancer to ensure
Advertising: Aoibheann Ní Shúilleabháin facts prevail when it comes to the HPV vaccine
Email: ipureview@ipu.ie
Tel: (01) 493 6401
13 Help to protect girls from
28
©2017
Copyright: All Rights Reserved,
Irish Pharmacy Union.
cervical cancer – promote
Printed by Ryson Colour Printers Ltd.
IPU Review is a Registered Trademark HPV vaccine
of the Irish Pharmacy Union.
16 Pharmacy Influenza
Vaccination Service Review
20 The 2017/18 ePortfolio Review
16
Q&A with Katherine Morrow, ePortfolio Review Project Lead, IIOP
28 Review of the Community
Pharmacy Sector
Key findings from the Review of the Irish Community
Pharmacy Sector 2015/2016 – Measuring the Contribution
IPUREVIEW SEPTEMBER 2017 3
LOOKING AFTER YOU AND YOURS SINCE 1970
Here’s to the next 40 years, when we look forward
to serving patients in Ireland even further.
For over four decades, Clonmel Healthcare has worked with GP’s and pharmacists to improve the quality of life for Irish patients,
making us the longest serving Generic partner in Ireland.
And with our commitment to the community – including a nurse specialist team – we’re also one of the most trusted names in
Generic medicine.
Our diverse product portfolio includes single source products that serve both the community and hospital markets, broadening our
reach into every corner of Irish life.
2013/ADV/GEN/052
www.clonmel-health.ie
32 Economic and Financial Update
for the Pharmacy Sector
36
36 The Pharmacist’s Role in
Treatment Adherence in
Asthma is Key to Saving Lives
44 Managing Pain in Pharmacy
50 CPD: Gallstones
54 Clinical Tips: Restrictions on
the use of Domperidone News
60
68 International News
56 High Tech Medicines Update: 69 Oropharyngeal Cancer and
Cimzia® 200mg Pre-filled Pen Human Papilloma Virus
70 Care Measures Required for Anti-
58 View from the Dispensary Depressant Medicines Outlined
New opinion column from pharmacist Caitriona O’Riordan 71 Pharmacies awarded
Crystal Clear Mark
60 Dismissing an Employee on Probation 72 Ireland’s first National Biosimilar
Medicines Policy aims to deliver
Advice on what employers should consider when more for patients and taxpayers
dismissing an employee during probation
72 Minister for Health says Dublin is
perfect new home for EMA
62 Plan ahead to get your business working
for you (not the other way around) 73 CarePlus Frontline Cycle
Advice on what you should consider when planning for your future 74 ‘Cycle for Hugh’s House’
raises €40k
66 Top Tips to Ensure Your Brand 74 Irish Chemists’ Golfing
Society News
Drives Business Growth
75 EU report: more evidence on
Branding tips that will help you drive business growth
link between antibiotic use
66
and antibiotic resistance
75 Health Reform Alliance
disappointed at missed
Sláintecare deadline
76 HIQA has launched a new
public consultation on eHealth
interoperability standards
development
32
76 Pfizer launches new translation app
77 Tony McEntee takes up Chief
Executive role at Sam McCauley’s
78 Product Information
79 Classified Ads
IPUREVIEW SEPTEMBER 2017 5
STOCKTAKING
A BC SERVICES
Celebrating 20 Years
Serving the Irish Pharmacy Community
1997 - 2017
PHARMACY SPECIALISTS / SAME DAY AUDITABLE REPORTS
LIVE STOCK INTEGRATION WITH:
44 CHURCH STREET, TULLAMORE, CO. OFFALY, R35 C1K6
Phone/Fax: 057 9320045
Alan Daly - Director: 087 2666431 Darren Donoghue - Manager: 086 3809082
E-mail: abcstocktakingservices@eircom.net Website: www.abcstocktaking.com
A NOTE FROM THE EDITOR Jack Shanahan MPSI
FMD Day is coming
Loath it or hate it, the Falsified Medicines Directive is yet another
extra layer of bureaucracy that is being added to our working day.
W
hile there is it, the dispensing process day rule, this authentication step in the dispensing
understandable stages will become a burning can only be reversed within process. The final step is
annoyance, concern in every pharmacy. this very limited time. Thus, typically when you supply
and concern, The legislation requires that if you have a prescription the medicines to the public
about more every pharmacy must confirm awaiting collection in the with suitable counselling. The
overbearing legislation every prescription medicine as pharmacy, once 10 days Falsified Medicines Directive
foisted on us from Europe, it being genuine. It is important pass by, you cannot put the is just another tool to assure
is important to accept that to understand that there are medicines back into stock drug quality, something the
this is a done deal. We will be two distinct processes. The for authentication again at a profession has been doing
legally obliged to do our part. first is verification. This will later stage. Up to that point since its inception. Part of this
There will be no exceptions. allow you to scan the unique you can effectively reactivate discussion will help refine
All prescription-only 2D barcode that will be on a medicine. This is critical in exactly what dispensing
medicines, including generics, every medicine placed on the most dispensary workflows. actually is. From modern
have to be authenticated, as market after FMD day to verify Many pharmacies do work pharmacy practice, it is clear
well as any non-prescription that it is genuine. This will balancing; they prepare that dispensing is inherently
drug that has been specified send the barcode information prescriptions in advance, a team process that usually
by the HPRA under the off to a central database. A ensuring efficiency. There is an involves many actors and,
regulation. For what it is few questions are answered: allied key consumer benefit in not infrequently, spans
worth, this legislation was Is the drug genuine? Has promoting safe work practices several days or weeks. It may
originally conceived and the drug ID already been by reducing haste. The incorporate non-supply. The
promoted exclusively by the decommissioned? Is the drug question then arises, at what days of looking at dispensing a
pharmaceutical industry in date? Is the drug subject to stage do you authenticate? prescription as pack and wrap
which was so concerned about a safety or withdrawal notice? To be properly informed, it is are gone. From the moment
counterfeit drugs entering It is important to note that important to understand that you assess the prescription
the supply chain that they verification does not change authentication is merely a as it arrives, to the time when
successfully lobbied for this the status of any medicine; supply chain function. There the patient leaves with or
comprehensive response. The this happens with the second is no requirement to associate without medicines, this is all a
structures required for an process, authentication. authentication with individual continuum of patient care.
effective rollout are already Verification can be used, if you patients. This is important as
in an advanced state of wish, to satisfy yourself that it removes the requirement to
preparation. Trials will start every medicine that comes have the PMR opened when
next year. into the pharmacy is genuine. you check to ensure you are
Thus, I found myself It would be of particular use not supplying counterfeit
sitting in a meeting where you want to transfer a drugs. This becomes more
recently discussing the medicine to a site that is not obvious when you realise
delights of forthcoming a consumer or patient, not as that some OTC medicines
medicines authentication part of a dispensing process. may be caught up under this
implementation when an So back to dispensing. We all directive. Currently, only OTC
important question arose: Is know what it is. We do it every omeprazole will be required
there a point in the dispensing day. We have SOPs up to our to be authenticated, probably
process when you can say, oxters about how it should be a legacy of the discovery
‘yes, that product is now done. A new concern arises: of falsified omeprazole in
dispensed’? While it may not When are we at immediate Germany in 2013. The way I
quite have the resonance pre-dispensing? Once an item see this working is that every
of how many angels can fit is dispensed, it is both verified pharmacy will have to have
on the head of a pin, it is and authenticated. This an authentication area, virtual
an important question. By 9 means that the specific pack or real. It will be here that
February 2019, FMD day, if you is marked as supplied to the products are scanned prior
haven’t already thought about public. Under the infamous 10 to supply, as the penultimate
If you have any comments, queries or issues to raise, send
your “Letters to the Editor” by email to ipureview@ipu.ie.
IPUREVIEW SEPTEMBER 2017 7
Pharmacy in
the Media
We issued a press release calling for medical card
holders to receive a smoking cessation service
and nicotine replacement therapy (NRT) directly
from their community pharmacy without the need
for a prescription. IPU President Daragh Connolly
commented on the issue saying that there should
not be barriers on GMS patients receiving a smoking
cessation service or any other service from their
pharmacist. There was significant coverage in national
newspapers including the Irish Examiner, Irish Daily
Mirror, Irish Sun, Irish Star and The Times Irish Edition, as
well as a further online article on IrishExaminer.com.
IPU member Tomás Conefrey was interviewed for
TV3 News at 5.30 to discuss the article published in the
Dates forry
British Medical Journal concerning the need to finish an
antibiotic course. He advised that this is not conclusive
your Dia
and patients should continue taking their antibiotics as
prescribed. Tomás was also interviewed for KFM Radio’s
Kildare Today on the matter.
2017
SEPTEMBER
ishheart.ie
onth, www.ir
Irish Heart M
are Week,
r Palliative C
3 - 9 Septembe epalliativehub.com
www.th
ide
r World Suic
10 Septembe ention Day,
Prev
.in fo/wspd
www.iasp
iploma
r IPU/ILM D
12 Septembe ad er sh ip &
in Le
an agem en t,
M
www.ip u. ie
my
r IPU Acade
18 Septembe um n Programme,
Aut
demy.ie
www.ipuaca
imer’s Day,
ptember World Alzhe
21 Se er.ie
www.alzheim
macists
r World Phar
25 Septembe , www .fip.org/
Day
acistsday
Vaccination
worldphar m
17
OCTOBER 20
Brea st Ca
9 October
ncer Aw areness, www
IPU Pharmac
Sa le s C
y
.cancer.ie
ourse,
Ad Campaign
Retail
www.ipu.ie We will launch a radio and digital media
ng for
er CPD Traini advertising campaign on 25 September to
9 – 15 Octob chnicians,
Pharmacy Te highlight that the flu vaccination service is
www.ipu.ie available in pharmacies. We have also produced
l Health
World Menta posters and leaflets to help you advertise your
10 October en talhealth
Day, www.m vaccination service, which are available to
ireland. ie download from the IPU website.
and
Mental Health
13 October lbeing Su m mit,
Wel
lh ealthand
www.menta
ng su m m it.com
wellbei
8 IPUREVIEW SEPTEMBER 2017
PharmaConex.com
IPU NEWS
WE
HAVE YOU
IPU Training COVERED
Programme
Autumn 2017 – NO.1
PHARMACY
Still Time to Book NEED
A LOCUM OR
RECRUITMENT
AGENCY IN
IRELAND
PERMANENT
Our successful training programme continues this autumn
with a wide range of courses, starting with the Diploma in
CANDIDATE?
Leadership & Management in mid-September. Our courses Our recruitment specialists
are designed to support pharmacists and pharmacy staff in will help you find
their continuing education. Please see the table below for the best fit for your
dates and locations of all of our upcoming courses. Book Pharmacy
early to avoid disappointment!
You can find details and application forms on the Training LOCUM WITH
& Events section of the IPU website, www.ipu.ie. Please PHARMACONEX
send completed application forms to training@ipu.ie or Full payroll
fax to 01 406 1556. If you have any questions in relation Online booking system
to these courses, you can phone Janice or Susan in the TRAIN 24/7 on-call team
Training Department on 01 406 1555. WITH Constant support
PHARMACONEX
Course Start Date
Diploma in Leadership Tuesday 12 September
& Management
IPU Medicines Counter Monday 25 September, Cork TRAINING
Assistant Course (MCA) Tuesday 26 September, Tullamore
Monday 25 September, Cork CPD Webinars
Tuesday 26 September, Tullamore
Monday 6 November, Dublin Clinical / Non-Clinical Training Days
Tuesday 7 November, Waterford
Dispensing Systems Training
Pharmacy Retail Sales Monday 9 October
Course New to Irish Pharmacy Training Programme
CPD Training for Monday 9 October, Cork
Pharmacy Technicians Monday 9 October, Cork
Topic 1: Heart Health (2) Monday 9 October, Cork All training information can be found on the
Topic 2: Commonly
Tuesday 10 October, Athlone Training & Events section of our website at
Tuesday 10 October, Killarney
Prescribed High Tech Drugs
Tuesday 10 October, Kilkenny www.pharmaconex.com
Wednesday 11 October, Dublin
Wednesday 11 October, Donegal
Wednesday 11 October, Limerick
Sunday 15 October, Dublin
IPU MCA Refresher Course Wednesday 18 October, Dublin
Wednesday 8 November, Cork
Supervisory Development Tuesday 24 October We have you covered
Course
DUBLIN: Suite 503, The Capel Building, Mary’s Abbey, Dublin 7.
T: +353 1 485 3522
SHANNON: Unit 8, Abbey House, Shannon Town Centre, Shannon, Co. Clare.
T: +353 6 153 0202
IPUREVIEW SEPTEMBER 2017 Emergency Number: +353 83 117 9967 - E: info@pharmaconex.com
IPU NEWS
IPU Academy Online
Autumn Programme: Interactive
18 September 2017 Polling
The IPU Academy Autumn Programme 2017 is now
at IPU
online at www.ipuacademy.ie, where you can view the
IPU Academy Autumn Programme 2017 and book your
courses. The five topics in the programme were selected
Academy
based on your feedback and will be delivered in venues
countrywide. This autumn, we are introducing
View the IPU Academy Autumn Programme and online interactive polling, using
book your courses in your smart phone or tablet, at IPU
3 easy steps. Academy courses. It is simple and
1. Log on to www.ipuacademy.ie. easy to use and will add to the
learning experience. We look forward
2. Enter your log-in details. to sharing this new tool with you at
3. Book your courses. courses in the upcoming programme.
The topics are:
IPU Business
n Diabetes in Practice;
n Clinical Skills for Community Pharmacists
Academy
(Express Topic);
C
n Cancer Management – Supportive Medicines M
(Express Topic);
Courses
Y
n Chronic Obstructive Pulmonary Disease; and
CM
n Bone Health.
MY
The IPU Academy Autumn Programme will start
The IPU Business Academy Autumn Programme
CY
on Monday 18 September and run until Wednesday
15 November. As a member of the IPU, you are will run from 13 September – 19 October in CMY
automatically a member of IPU Academy. This venues across the country. We endeavour to K
membership benefit entitles you to attend, without provide members and their staff with the best-
charge, live learning events in the IPU Academy Autumn
in-business training programmes and workshops
Programme.
to help you maximise your pharmacy’s
performance. Courses in Digital Marketing
(beginners and advanced levels) and Sales and
Merchandising are included in our programme.
More information is available in the Training &
Events section of the IPU website, www.ipu.ie. If
you have any queries, please contact Darren Kelly
at darren.kelly@ipu.ie.
Pharmacy Benevolent Fund clg Confined Monthly Draw
The winners of the August draw were:
1st Prize (€1,000): Brendan Loftus, Bunclody.
2nd Prize (€500): Eoghan Hanley, Loughrey.
Thank you to all the contributors for their continued support.
10 IPUREVIEW SEPTEMBER 2017PROFESSIONAL
Organisations sign ‘Contract
Against Cancer’ to ensure
facts prevail when it comes
to the HPV vaccine
The HPV Vaccination Alliance is a group of more than
30 organisations, including the Irish Pharmacy Union,
that have come together to sign a contract against
cancer, specifically HPV-related cancers.
R
ecent media organisations from the health,
coverage shows children’s and women’s
a fall-off in sectors come together to
uptake of the HPV encourage everyone to look
vaccine, which is at the facts surrounding this
offered to first-year second life-saving vaccine. In coming
level school girls each year. together, the HPV Vaccination
The vaccine protects against Alliance is unequivocal:
strains of the HPV virus which the HPV vaccine is safe and Under the contract, the
causes seven in 10 of all cases saves lives. To highlight HPV Vaccination Alliance:
of cervical cancer, as well as this, Alliance member
a number of other cancers organisations have signed a n Endorses the HPV n Realises its obligation to
that affect men and women. Contract Against Cancer. vaccine as a proven do all it can to protect
The HPV Vaccination Alliance and safe way to protect health and wellbeing
has been set up ahead of the from cancers which can by ensuring the facts
new school year and will see destroy and end lives; prevail when it comes to
the HPV vaccine; and
n Pledges to raise
awareness of the HPV
vaccine and its benefits
in stopping cancer
and saving lives.
For more information on the
HPV Vaccination Alliance and
its Contract Against Cancer,
please see www.hpvalliance.ie.
Pictured at the launch of the HPV
Vaccination Alliance were Tanya Ward,
Chief Executive of the Children’s
Rights Alliance; Donal Buggy, Head of
Services and Advocacy, Irish Cancer
Society; and Orla O’Connor, Director
of the National Women’s Council of
Ireland (NWCI).
12 IPUREVIEW SEPTEMBER 2017PROFESSIONAL Dr Niamh O’Callaghan, Specialist Registrar in Public Health Medicine,
HSE National Immunisation Office
Help to protect
girls from cervical
cancer – promote
HPV vaccine
H
u m a n p a p illomavirus n igh vaccine spontaneously. However, some
H m o st commo
uptakes are chronic infections caused by
(HP V ) is t h e the key to the oncogenic or ‘high-risk’ HPV
smitted
success of this types can progress to cervical
s e xu a lly t ra n vaccine but there cancer. Almost all cervical
c t io n w o rld wide and are concerns that uptake cancer is caused by HPV
infe a l c a ncer as
rates are falling due to alleged infection.
cause s c e r vic safety issues. This article In Ireland, almost 300
ryngeal,
describes the disease burden, (mostly young) women
ll a s o r o p h a vaccine safety and impact, develop cervical cancer each
we il e a nd anal and outlines the important year and almost 90 women die
vagin a l, p e n
ccine
role of the pharmacist. because of it2. Furthermore,
T h e H P V va each year, over 6,500 women
cancers. ffe ct ive and Human papillomavirus
are diagnosed with high-
is safe a n d e and the disease burden
grade cervical intraepithelial
duction
neoplasia (CIN) caused by
s le d to a re high-risk HPV infection3.
ha ous
Human papillomavirus
in precancer ns.
These precancerous lesions
(HPV) is the most common
have the potential to develop
sexually transmitted infection
cervical lesio
into invasive cervical cancer if
worldwide1. The virus is spread
not treated.
by direct (usually sexual)
contact with an infected
person and most sexually HPV vaccine
active people will have an
asymptomatic HPV infection Two HPV vaccines (HPV2 and
in their lifetime. Infection is HPV4) were first licensed in
most common in people in 2006 to prevent premalignant
their late teens and early 20s. genital lesions (cervical, vulvar
Infections generally resolve and vaginal) and cervical
cancers causally related to HPV
types 16 and 18. These two HPV
types are responsible for 70% of
IPUREVIEW SEPTEMBER 2017 13cervical cancers. HPV vaccines Figure 1: National % uptake of HPV vaccine by academic year professional oncology society
may be given to females from treating cancer, “implored”
nine to 26 years of age. the healthcare provider
The HPV4 vaccine, Gardasil, community in countries to
is also licensed to prevent increase HPV vaccination to
premalignant anal lesions and lessen the burden of cancer
anal cancers and provides for patients, their families
protection against HPV types and communities6. All girls
6 and 11 that cause over in first year of second level
90% of genital warts in men school should receive the
and women. HPV4 vaccine is HPV vaccine to prevent
licensed for use in males from cervical cancer. However,
nine years of age. due to unfounded public
The HPV4 (Gardasil) concerns about vaccine
vaccine is over 99% effective safety, it is likely that the
in preventing cervical reduced HPV vaccine uptake
intraepithelial neoplasia will leave several thousand
associated with HPV types 16 girls unprotected. This is of
and 18 in young women and great concern to all those
99% effective in preventing involved in cancer prevention.
genital warts associated with There is evidence that
HPV vaccine safety over 200 years. It is 3 – 4 times
HPV types 6 and 11. A new more common in females the recommendation of a
HPV9 vaccine (Gardasil 9) More than 227 million doses and even more common known health professional,
was licensed in 2014, which of HPV4 vaccine have been in younger adolescents. In such as a pharmacist, can
provides protection against distributed worldwide and in Ireland, estimates suggest a lead to increased vaccine
oncogenic HPV types 16, Ireland, more than 690,000 prevalence rate of 0.2 – 0.4% uptake. The HSE National
18, 31, 33, 45, 52 and 58. doses have been distributed (similar to that reported in Immunisation Office has
These seven HPV types are and more than 230,000 girls other European countries) so produced fact sheets and
responsible for almost 90% of have been vaccinated. The at least 440 – 880 cases of CFS posters for pharmacists and
cervical cancers. safety of the HPV vaccine would have been expected by the general public, which will
has been monitored for more chance among the 220,000 be distributed in the coming
than 10 years. International vaccinated girls5. The numbers weeks. Pharmacists can
HSE School Vaccination bodies, including WHO, the US reported are much lower than play a significant role in the
Programme Centers for Disease Control expected. Scientific studies, promotion of HPV vaccination
and Prevention (CDC) and the amongst them a recently so please help us to inform
On the recommendations
European Medicines Agency published major Norwegian parents about its safety
of the World Health
(EMA) have continually study involving over 175,000 and effectiveness. For more
Organisation (WHO) and
reported that the vaccine is girls, have found that girls information, visit www.hpv.ie.
the National Immunisation
safe with no known long- who have received the HPV
Advisory Committee (NIAC),
term side-effects. The WHO vaccine are at no greater risk
the HSE has offered the HPV References
Global Advisory Committee of CFS than those who have
vaccine to all girls in first year 1. National Immunisation Advisory
for Vaccine Safety (GACVS) not received the vaccine.
in second level schools since Committee (2015) Immunisation
reported in July 2017 that HPV Guidelines for Ireland. Dublin: Royal
2010 to protect them from
vaccines are “considered to be College of Physicians of Ireland.
cervical cancer in adulthood.
The vaccine is offered to
extremely safe”4. Impact of HPV vaccine Available at: www.hse.ie/eng/health/
There is no scientific immunisation/hcpinfo/guidelines/
this age group because the HPV vaccines are more chapter10.pdf.
evidence that there has been 2. National Cancer Registry (2015)
response to the vaccine is than 99% protective against
an increase in the incidence Cancer in Ireland 1994-2013:
best at this age. The HPV4 cancer-causing HPV viruses.
of chronic fatigue syndrome Annual Report of the National Cancer
(Gardasil) vaccine has been Countries with high vaccine Registry. Cork: NCR.
or any other long-term
used in the HSE vaccination uptake rates have seen the 3. The National Cervical Screening
medical condition after the Programme (in press) CervicalCheck
programme since 2010. greatest beneficial impact. In
introduction of the HPV – The National Cervical Screening
Currently, two doses, Scotland, where 90% of girls
vaccine in 2006. In the US, Programme Report 2015 – 16.
six months apart, are have been vaccinated since Dublin: National Screening Service.
from June 2006 to September
recommended for girls up to 2008, there has been a 90% 4. WHO (2017) WHO Meeting of
2015, 80 million doses of
15 years of age. Girls aged 15 reduction in HPV infections in the Global Advisory Committee on
Gardasil were distributed Vaccine Safety, 7 – 8 June 2017.
years and older need three those vaccinated. Countries
and there were 13 reports Available at: www.who.int/vaccine_
doses of the vaccine to be such as Australia, Sweden safety/committee/topics/hpv/en/.
of postural orthostatic
protected as, to date, there is and Scotland have seen a 50% 5. Irish ME/CFS Organisation (2009)
tachycardia syndrome (POTS),
no evidence to support a two- reduction in precancerous CFS Information.
a symptom also investigated 6. Bailey, H.H., Chuang, L.T., DuPont,
dose schedule. Vaccine uptake growths of the cervix.
by the EMA. Neither the CDC N.C., Eng, C., Foxhall, L.E., Merrill,
has exceeded the target of 80% J.K. et al. (2016) American Society
nor the EMA have detected
since 2010/11. However, this of Clinical Oncology Statement:
any safety concern with
uptake fell to 72% in 2015/16
POTS or other chronic fatigue
Pharmacist Human Papillomavirus Vaccination
and it is estimated that only
syndrome like conditions recommendation for Cancer Prevention. J Clin Oncol
[online]. 34(15), 1803-12. Available
50% of girls received their first
following HPV vaccination. In April 2016, the American at: https://www.ncbi.nlm.nih.gov/
dose in 2016/17 due to vaccine pubmed/27069078.
Chronic fatigue syndrome Society of Clinical Oncology,
safety concerns (see Figure 1).
(CFS) has been known for the US leading medical
14 IPUREVIEW SEPTEMBER 2017Available in pharmacy
But emergency contraception has.
ellaOne® is the most effective emergency contraceptive pill1
www.ellaonepharmacists.ie
exécution
Further information available from:
30, rue Saint-Augustin
75002 PARIS (France)
tél. : +33 (0)1 42 66 46
fax : +33 (0)1 42 66 4
www.byagencydesign.
01 13 / 03 / 14
HRA Pharma, Haines House, 21 John Street, Bloomsbury, WC1N 2BF, London.
ÉTAPE / STEP : DATE :
DOCUMENT D’EXÉCUTION / ARTWORK FILE :
HRA Pharma Women Health Circle Quadri Com
CLIENT : HRA Pharma
Freephone: 1800 812 984. Email: med.info.ie@hra-pharma.com
FICHIER / FILE :
HRA Pharma Women Health Circle Quadri Com.eps
LOGICIEL / SOFTWARE :
Illustrator CS6
DIMENSIONS / SUPPLIER :
ÉCHELLE / SCALE : 100 %
Adverse events should be reported. Reporting forms and information can be
PLAN / CUTTING LINES :
IMPRESSION / PRINTING PROCESS :
*unprotected sexual intercourse
OFFSET
SUPPORT / PRINTING MEDIUM :
found at www.hpra.ie. Adverse events should also be reported to HRA UK &
WHITE CARDBOARD
POLICES / FONTS :
GILL SANS
Ireland Ltd on Freephone: 1800 812 984 or email: med.info.ie@hra-pharma.com IE/ELLA/0216/0003 DOCUMENT TECHNIQUE RÉALISÉ EN
ARTWORK REALISED IN 4 COULEURS
PROCESS CL
Quadri
1. Glasier AF et al. Lancet 2010; 375: 555-62. Date of preparation: March 2016
BRAILLE :
artwork
DOCUMENT D’EXÉCUTION
Ce document nécessite l’aperçu de la
surimpression pour sa visualisation complèt
WARNING l’impression de la surimpression pour effect
une sortie correcte. La réalisation technique
C 86, M 100, J 30 que la surimpression des encres, les grossi-maigri, le
recouvrements, restent à l’entière charge de l’imprime
La taille et les positionnements des Gencods sont à vali
par le fabricant. Un BàT imprimeur doit être soumis a
C40, M30, J30, N0 C 68, M 72, J 0, N 0 GillSans Bold client avant l’impression définitive.
ARTWORK FILE
Please make sure to check the artwork with the Overpr
Preview is on.
Trapping, overprint colours,
colour adjustments, must be processed in photoengrav
Barcods must be checked by the Printer.
A Printer Approval is required before the final printinPROFESSIONAL Pamela Logan MPSI, Director of Pharmacy Services, IPU
Pharmacy
Influenza
Vaccination
Service Review
2017/18 will be the seventh season that Irish
community pharmacists have been involved in the
HSE Seasonal Influenza Vaccination Campaign. In this
article, Pamela Logan, Director of Pharmacy Services,
IPU, reviews the pharmacy influenza vaccination
service and looks at other vaccinations suitable for
community pharmacy provision.
S
easonal influenza Flu Vaccination in Irish
has to be taken community pharmacies
seriously. Each
year, approximately In Ireland, the pharmacy
10% of Europe’s influenza vaccination service
population is infected continues to grow. As shown
and influenza-related in Table 1, the number
complications cause of patients vaccinated in
hundreds of thousands community pharmacy
of hospitalisations across continues to increase year
Europe. Older people, younger on year, with the 2016/17
children and those with season seeing a total of 78,935
chronic conditions suffer vaccinated across the 762
the most, but everyone is at pharmacies which provided
risk of developing serious the service. This is an increase
complications – which include of 26% on the previous season.
pneumonia, myocarditis and Pharmacy flu vaccination now
encephalitis – that may result accounts for around 10% of
in death. the total flu vaccinations.
16 IPUREVIEW SEPTEMBER 2017Figure 1: Flu Vaccinations in Community Pharmacies 2011 – 2017 n 84% of respondents said
they had received the
Season 2011/ 2012/ 2013/ 2014/ 2015/ 2016/ flu vaccination before.
2012 2013 2014 2015 2016 2017 Overall, almost a third
indicated it was their
first time receiving
No. of flu vaccinations 9,125 18,358 40,991 51,227 62,514 78,935 the flu vaccine in a
pharmacy.
n 19 out of every 20
Figure 2: Seasonal Influenza vaccination coverage rates in older age groups respondents said they
in EU/EEA Member States, 2011 – 12 and 2012 – 13 influenza seasons were very satisfied
with the amount of
information received at
the time of vaccination.
n 99% said that they would
be likely to go to the
pharmacist for their flu
vaccination again.
n Patient satisfaction
with the pharmacy-
delivered flu vaccination
service is high; 79% of
respondents rated their
overall satisfaction as
10 out of 10; 93% rated
overall satisfaction as 9
or 10 out of 10; 99% of
respondents rated their
overall satisfaction as
either 8, 9 or 10 out of 10.
Source: ECDC National Seasonal Influenza Vaccination Survey, March 2014
Flu vaccination
coverage in the EU
In 2009, the EU Council
recommended that Member
States should reach a
vaccination coverage rate
of 75% by 2014/15 for
persons aged 65 years and
older, people with chronic
medical conditions, pregnant
women and young children,
and, also, that vaccination
coverage among healthcare
workers should be improved.
Nevertheless, only the
Netherlands and the UK have
achieved the 75% target for
vaccination in older people
(Figure 2). Very few Member
States record vaccination
coverage rates for people with
chronic conditions. Satisfaction with Service
Patient feedback on
pharmacy vaccination
In March 2016, the
Pharmaceutical Society of
Ireland (PSI) published the
results of a survey on patient
feedback about the flu
vaccination service provided
in community pharmacies.
IPUREVIEW SEPTEMBER 2017 17Patient motivation to attend pharmacy for flu vaccination
n Reasons for attending nursing homes or other not remunerate pharmacies weaknesses, all Member
a pharmacy for the residential care settings, for these vaccinations. In a States need to reconsider
flu vaccination were especially against seasonal meeting with the Minister their approach in order to
convenience of access, influenza. At that time, last year and a follow-up collect more comprehensive
efficiency (longer influenza hospitalisations and letter in July this year, the IPU and accurate information on
opening hours, no need outbreaks in residential care requested that pneumococcal vaccination coverage for all
for appointments etc.), facilities were at high levels. vaccination in pharmacies be of those population groups
trust in pharmacist and Given the current shortage included in the HSE national that are targeted for seasonal
cost. On a scale of 0 to of GPs and its predicted programme. influenza vaccination, in
10, 74% of patients rated worsening in the future, steps order to enable public health
trust in the pharmacist must be taken to ensure that organisations to track their
as 9 or 10 (most all patients in residential care Other vaccinations progress and identify obstacles
important factor) for facilities have ready access In December last year and to achieving national and EU
attending a pharmacy to a healthcare professional again in April this year, a targets. The HSE vaccination
for the vaccination. who can provide appropriate proposal was sent to the portal, which pharmacists
and timely vaccinations. The Minister to further expand use to record all vaccines
Respondents were also
IPU believes that this could the range of vaccines that administered, could form the
asked their opinions on having
and should be their local pharmacists are permitted basis of such a system and
other vaccines and services
community pharmacist. to supply and administer. supports the appropriateness
available from a community
Improving access to and The proposal considered all of pharmacies as a location
pharmacy. Specific examples
uptake of vaccination would vaccines within the guidelines for receiving vaccinations.
were provided and there was
go some way towards assisting produced by the National There is still great potential
generally positive response to
in reducing demand on A&E Immunisation Advisory for the pharmacy vaccination
the suggestion of expanding
and hospital services. Committee (NIAC) and made service to grow. The HSE
the range of health services
recommendations as to the estimates that, between older
and vaccinations provided by
suitability of certain selected people and at-risk people, over
a pharmacist. Pneumococcal vaccines for a Pharmacy one million people should be
and shingles Vaccination Service. vaccinated in Ireland. As the
Pharmacy vaccination population ages and chronic
Last season, pharmacists were
disease rates keep increasing,
in nursing homes enabled to vaccinate against
pneumococcal disease and Conclusion this cohort will continue to
In January 2017, the IPU wrote grow. Meanwhile, we still
shingles. Unfortunately, the The ability to monitor
to the Minister for Health await a response from the
uptake levels were very low, vaccination coverage is
proposing that pharmacists Department of Health to
at 164 and 64 respectively. a key component of any
should be facilitated in the various proposals to the
The main reason for low vaccination programme. In
vaccinating patients in Minister which are detailed
uptake was that the HSE does order to identify gaps and above.
“There is still great potential for the
pharmacy vaccination service to grow.
The HSE estimates that, between older
people and at-risk people, over one million
people should be vaccinated in Ireland.”
18 IPUREVIEW SEPTEMBER 2017No.1 Selling
Rehydration
Treatment1
Rehydrate STOCK
NOW
right with
Are your customers suffering from diarrhoea?
If yes, they may be dehydrated. Trusted by Pharmacists for over 30 years
Dehydration is a serious side effect of acute Meets ESPGHAN2 and NICE3 guidelines
diarrhoea especially in children and the elderly. for oral rehydration
Suitable for children aged 12 months and up*
can help your customers to
Available to stock in a convenient CDU
rehydrate right and recover fast.
References: 1. Data on File - Dioralyte Sales in Ireland (IE.OTC.14.02.03(1)a) 2. ESPGAN Working Group. J Pediatr Gastroenterol Nutr 1993;14:113-115.
3. NICE, Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management. Clinical guideline [CG84]. Published date: April 2009.
* Under 12 months old administer under medical advice.
TO PLACE AN ORDER WITH YOUR SANOFI REPRESENTATIVE CALL:
Padhraic Speight Colm Moran Laurence O’Carroll
Tel: 086 0456 817 Munster Tel: 086 0470 989 Midlands, North West Tel: 086 0456 816 East Coast
PRESCRIBING INFORMATION indicated in pregnancy or lactation. Interactions and Adverse Effects: None stated. Overdose:
DIORALYTE™ NATURAL, BLACKCURRANT AND CITRUS, POWDER FOR ORAL SOLUTION In the event of significant overdose, serum electrolytes should be evaluated as soon as possible,
Presentation: Sachet containing the active ingredients Sodium Chloride 0.47g, Potassium correct any abnormalities and monitor levels until return to normal, especially in the very young
Chloride 0.30g, Glucose 3.56g and Disodium Hydrogen Citrate 0.53g. Indications: Oral and in cases of severe hepatic or renal failure. Precautions for Storage: Do not store above
correction of fluid and electrolyte loss and the management of watery diarrhoea in infants, 25°C. The reconstituted solution should be used immediately but may be stored for up to
children and adults. Dosage and Administration: Each sachet should be reconstituted in 200ml 24 hours in a refrigerator at 2-8°C. Marketing Authorisation Holder: Sanofi Ireland Ltd.,
(approximately 7 fluid ounces) of fresh drinking water. For infants where fresh drinking water is Citywest Business Campus, Dublin 24. Marketing Authorisation No. PA 540/98/1 (Blackcurrant),
unavailable the water should be freshly boiled and cooled. The solution should be made up PA 540/98/2 (Citrus), PA 540/99/1 (Natural) Legal Category: P Further information: Available
immediately before use. If refrigerated, the solution may be stored for up to 24 hours, otherwise from Sanofi Ireland Ltd., Citywest Business Campus, Dublin 24 or contact IEmedinfo@sanofi.
any solution remaining an hour after reconstitution should be discarded. The solution must not com. Please refer to Summary of Product Characteristics which can be found on IPHA at
be boiled after reconstitution. Daily intake may be based on a volume of 150ml/kg body weight http://www.medicines.ie/ before prescribing. Date of Preparation: January 2016
for infants and 20-40 mg/kg body weight for adults and children. A reasonable approximation
is: Infants – One to one and a half times the usual feed volume. For infants under 12 months, use Reporting suspected adverse reactions after authorisation of the medicinal
only under medical advice. Children – One sachet after every loose motion. Adults (including product is important. It allows continued monitoring of the benefit/risk balance of
elderly) – One or two sachets after every loose motion. More may be required initially to ensure the medicinal product. Healthcare professionals are asked to report any suspected
early and full volume repletion. Contraindications: None known. Warnings and Precautions: adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2;
The solution must not be reconstituted except with water at the volume stated. Solutions of Tel: +353 1 6764971; Fax: +353 1 6762517. Website: www.hpra.ie; E-mail: medsafety@hpra.ie.
greater concentration may result in hypernatraemia. Those of greater dilution may result in Suspected adverse events can also be reported to Sanofi Ireland Ltd. directly by emailing
inadequate replacement. If there is no improvement within 24-36 hours, consult the physician. IEPharmacovigilance@Sanofi.com or calling 01 403 5600.
If nausea and vomiting are present with the diarrhoea, small but frequent amounts of dioralyte
should be drunk at first. No specific precautions are necessary in the elderly. However, caution
is required in cases of severe renal or hepatic impairment or other conditions where the normal Date of Preparation: March 2017
electrolyte balance may be disturbed. Pregnancy and Lactation: Dioralyte is not contra- SAIE.DIO.17.01.0010bPROFESSIONAL
The 2017/18
ePortfolio
Review
The Pharmaceutical Society of Ireland (PSI) Continuing
Professional Development (CPD) Rules 2015 (SI No 553 of
2015) came into effect on 1 January 2016. These rules set
out the legal framework to give effect to the PSI’s
CPD model including a system of quality
assurance of pharmacists’ CPD.
T
he system of very positive. This is an
quality assurance impressive result and gives a
known as the very positive early indicator
ePortfolio Review for the level of engagement
process is carried and commitment of the
out by the Irish Institute of profession with CPD.
Pharmacy (IIOP). The ePortfolio The PSI has now completed
Review is the process by which a random selection of over
pharmacists are required to 1,300 pharmacists for the
submit an extract from their second ePortfolio Review
ePortfolio which demonstrates and notified the selected
that they are appropriately pharmacists by email on
engaging in CPD. Pharmacists 25 July 2017. Pharmacists
can expect to be called by selected for review will
the PSI to participate in an be invited to submit their
ePortfolio Review once in every ePortfolio extract for review by
five year period. the IIOP in January 2018.
The first statutory ePortfolio In the early stages of this
Review was completed in second review, Liz Hoctor,
May of this year. Over 90% Professional Development
of pharmacists participating and Learning Manager, IPU,
in the review demonstrated sat down with Katherine
compliance with the review Morrow, ePortfolio Review
standards and the IIOP Project Lead, IIOP, to discuss
reported that the feedback some of the commonly
from participants was broadly asked questions.
20 IPUREVIEW SEPTEMBER 2017WE ARE GROWING!
Are you a young Pharmacist looking
to own your own business?
Talk to us today about turning your
dream into a reality with Ireland’s
fastest growing Pharmacy Group.
Contact Joey McNamara,
Head of Network Development
086 607 6019 GROW WITH US @
growwithus@careplus.ie1. How does the creation date retrospectively. you undertook in 2016. It to use to prompt reflection.
For example, if you wish to is possible that in some The standards for the
review work?
record a learning cycle from instances cycles may remain 2017/18 review require that
The IIOP ePortfolio Review November 2016, simply select open for several years, e.g. pharmacists submit at least
process enables pharmacists this date at the ‘Cycle Start if the learning is linked to one CPD cycle which has
to submit extracts from Date’ stage. a long-running educational originated from their self-
their ePortfolio for review by programme, such as a assessment against the Core
the IIOP. These extracts are diploma or a Masters, which Competency Framework for
then objectively reviewed 3. I started using my is perfectly reasonable and Pharmacists. For the purposes
against a pre-determined ePortfolio in 2015. appropriate. This is one of of the review, this can be done
set of standards, which the reasons that the system- in one of two ways:
are published on the IIOP
Can I select entries
based review recognises cycle
website for all pharmacists from 2015, 2016 and creation dates and not cycle
n By undertaking a
to view. This ensures a fair 2017 for review? completion dates.
CCSAT self-assessment,
and transparent process for exporting the
It is important that the cycles
pharmacists. suggested cycle topics
in your extract meet the
The standards for this standards for the current 5. I wasn’t selected into your ePortfolio,
review were set by a group of then completing and
review. For this year, the this year and I am
‘real’ pharmacists, working submitting at least one
standards stipulate that at going to travel for
day-to-day in a range of cycle for review; or
least four cycles from 2017(18)
different practice settings. and at least one cycle from the
2018. If I am selected
n By selecting the tick box
Therefore, the standards set previous four years (i.e. from next year for the under the Self-Appraisal
are representative of what 2013 – 2016 inclusive) must 2018/19 ePortfolio stage of the relevant
this group consider to be
reasonable engagement with
be submitted. So yes, you can Review, can I select cycle, ‘Completing self-
select cycles from all years as assessment against
CPD for everyday working entries from 2017?
long as you include four from the Core Competency
pharmacists, in line with the 2017(18). Remember, however, If you are selected in 2018, Framework’.
specific requirements of the that the number of cycles it is likely that you will
legislation. represents just one part of the need to submit evidence Further instructions on this
review requirements, so check of ongoing learning. As will be included in the online
your extract carefully against pharmacists, we need to be ePortfolio Review support
2. I have been able to demonstrate to our resources, which will be
the other standards for review.
recording my cycles The standards can be accessed patients, our colleagues and available to pharmacists from
in a notebook, not by a link from the homepage the general public that we are mid-September.
continuously learning and
online. Now that I have of the IIOP website (www.iiop.
ie). When the time comes to developing in order to stay
been selected for the up-to-date in our knowledge 7. I completed the
submit your extract, you will
ePortfolio Review, I am be able to avail of a ‘ready and skills, which is why the Core Competency
going to record them reckoner’ tool which allows legislation requires that CPD is Self-Assessment Tool
recorded contemporaneously. (CCSAT) in August
in my ePortfolio next you to check if your extract
meets the requirements of Whilst the standards for
weekend, so it will the 2018/19 review have not 2016 and completed a
the system-based standards.
look like I completed In the event that further yet been set, it is likely that CPD cycle based on the
all my CPD on the action is required, you can there will be a requirement to outcome in 2016. Can
same date. Will this submit additional cycles as provide evidence of CPD from I submit this as a cycle
long as this is done within the the current year (i.e. 2018), as
matter? well as from previous years.
which originated from
specified timeframe.
The standards for the 2017/18 Remember, the ePortfolio my self-assessment
review require that you is accessible via all mobile against the PSI’s
submit at least four cycles 4. Since 2015, I have electronic devices so you Core Competency
that you created in 2017 (or can add to your ePortfolio as
been recording entries Framework for
in 2018 during the current you travel. There are likely to
review process) and at least in my ePortfolio but I be ways in which travelling Pharmacists for
one cycle that you created in haven’t finished any experiences can add to your assessment in the
the previous four years (i.e. CPD cycles. I have professional development. 2017/18 ePortfolio
2013 – 2016 inclusive). This been selected for the
is to reflect the legislative Review?
requirement to record your 2017/18 ePortfolio 6. Do I have to No, as this does not reflect
CPD in your IIOP ePortfolio Review. Can I finish a complete the CCSAT? evidence of recent self-
on an ongoing basis. 2016 cycle now and The CPD legislation for
assessment. The standards
Therefore, if you have been for this year’s review stipulate
submit this as a cycle pharmacists requires that
using a notebook, it is very that you must provide
important that you familiarise
created last year? all pharmacists regularly
evidence of self-assessment
self-assess against the PSI’s
yourself with the ePortfolio Yes, you can. Whilst you against the PSI’s Core
Core Competency Framework
and start using it now. You may not have ‘finished’ or Competency Framework for
for Pharmacists. The CCSAT
can transfer your cycles ‘completed’ your cycle, the Pharmacists in the current
provides a record of this self-
from your notebook to your cycle still demonstrates year. This is in line with the
assessment and is a good tool
ePortfolio and record the cycle evidence of learning that legislative requirement to
22 IPUREVIEW SEPTEMBER 2017Our passion is in the detail
There are occasions when your patients have to deal with difficult challenges and you may
need to arrange for special medicines. PharmaSource can help you source these medicines
in a timely, reliable and safe manner.
With over 70% of Irish pharmacies ordering from us every day, we are Ireland’s leading
supplier of unlicensed medicines, manufactured specials and once off procured items
to the Irish market. Our service is tried and tested and valued by our loyal customers.
PharmaSource can help reduce the valuable time our customers are spending searching
for medicines that are currently in short supply or discontinued in the national market.
We can source these products for you, simply give our team a call.
• Our team is made up of qualified • PharmaSource was the first to • We have an unparalleled range
pharmacists and pharmacy market with our website. Others of over 3,000 products in stock,
technicians who understand the have tried to mimic but none can including cold chain and controlled
importance of delivering your compare. Our site allows you to drugs and have immediate access
order on time every time. When check stock levels in real time, to a database of more than 4
you call PharmaSource you will be confirm pricing, reprint monthly million medicines worldwide.
speaking to your peers. invoices and keep a record of what • We are one of the most
unlicensed medicines you have competitively priced, with no
ordered for audit purposes. Placing minimum order charge.
your order with PharmaSource has
never been easier.
• We also offer a Saturday delivery.
For more information please contact:
• Free Phone 1800 440 440 • Free Fax 1800 441 441
• Email PharmaSource@uniphar.ie • Web www.uniphar.ieregularly self-assess against n Researching a new
the framework. For this review, drug that has been
there are two ways that you prescribed for a patient.
can demonstrate evidence
However, it is important
of this self-assessment, as
to remember that recording
described above.
any learning activity may
“Attending IPU
be appropriate as long as
8. How much you can demonstrate how
it has contributed to your
information should
I record in my CPD Academy lectures, professional development.
It may be helpful to refer to
entries?
for example, is
the standards for this year’s
There is no right or wrong review to see types of criteria
answer to this; it depends within the scope of the review.
on the cycle itself and what
it is you are recording. For
a very valuable The standards can be accessed
by a link from the homepage
means of
example, recording a cycle of the IIOP website.
based on a discussion with a
colleague or a cycle based on
learnings from a work-related
incident may differ from one
undertaking CPD 10. I have been
selected for the
based on a formal course of
study. It all depends on the
basis for the cycle and the
and also offers ePortfolio Review and
have some CPD cycles
stage at which the cycle was
started (e.g. the Self-Appraisal
opportunities to recorded. I have just
been involved in an
stage, Develop a Personal Plan
stage or Action stage). Each
pharmacist will have his or
engage with your accident and will be
unable to work for
her own style; some choose to
use bullet point information,
colleagues which the next six months.
Can I now apply
while others prefer to be more
detailed. What is important, may lead to other for an exemption
due to extenuating
opportunities
however, is that you
circumstances?
sufficiently detail what you
have learned and how that The PSI manages all
learning has contributed to
your understanding, benefited for CPD.” applications for exemptions
from the review under its
Extenuating Circumstances
your practice, improved
patient outcomes or advanced process. If circumstances
your continuing professional apply to you which would
development. You will find have an impact on your ability
some sample CPD cycles CPD. Traditionally, many Attending IPU Academy to submit an extract from your
on the IIOP website, in IIOP pharmacists focus their CPD lectures, for example, is ePortfolio, you should contact
newsletters or by attending on their clinical expertise. a very valuable means of the PSI. The PSI’s Extenuating
ePortfolio Review information The PSI’s Core Competency undertaking CPD and also Circumstances Policy and the
events. You should write in a Framework for Pharmacists offers opportunities to relevant application form are
way that works for you and indicates that pharmacists engage with your colleagues available on the PSI website.
allows you to reflect on what must be competent across which may lead to other All applications submitted
you have done. six domains of practice: opportunities for CPD. Other will be managed by the PSI on
Professional Practice, Personal examples of activities that can a confidential case-by-case
Skills, Supply of Medicines, be recorded in your ePortfolio basis. As per the PSI’s initial
9. I go to IPU Academy Safe and Rational Use of as CPD include: communication, applications
courses and have Medicines, Public Health and for exemption on the basis of
n Completing an extenuating circumstances
completed some Organisation & Management
eLearning course; should have been made before
Skills. It is important to aim
of the IIOP online to keep upskilled across all n Attending a live 25 August 2017. In situations
courses; are there six domains, not just those learning course; where unforeseen extenuating
other activities that domains relating to medicines. circumstances arise outside of
This requires engaging in a n Reading an article; this timeframe but during the
I could record in my review process, applications
breadth of learning. n Having a discussion
ePortfolio? Consequently, there are should still be made to the PSI
with a colleague;
Many pharmacists are many different types of and should include evidence
surprised to realise the activities that can be recorded n Attending a as to why it was not possible
breadth of what counts as in your ePortfolio as CPD. conference; and to submit in advance of the
specified deadline.
24 IPUREVIEW SEPTEMBER 2017You can also read
